Comprehensive Analysis of Bortezomib-Induced Adverse Events Using the Japanese Real-World Database.
Bortezomib is used as first-line therapy for multiple myeloma. Observational studies based on the FDA Adverse Event Reporting System (FAERS) database analysis and systematic reviews indicate...